Table 2.
Variable, Strata Range | Hospital-Associated CDI | |||
---|---|---|---|---|
No. of CDI |
No. of Admissions |
CDI per 10,000 Admissions |
P Value | |
High-risk antibiotic use, day of therapy per 1,000 days present | ||||
1st quartile (77–193) | 2,902 | 909,380 | 31.9 | Reference |
2nd quartile (194–241) | 2,851 | 837,128 | 34.1 | .0135 |
3rd quartile (242–295) | 2,523 | 671,853 | 37.6 | <.0001 |
4th quartile (296–440) | 2,029 | 561,172 | 36.2 | <.0001 |
Proportion of patients age >65, % | ||||
1st quartile (0.14–0.33) | 3,080 | 1,044,253 | 29.5 | Reference |
2nd quartile (0.34–0.38) | 1,685 | 556,608 | 30.3 | .3899 |
3rd quartile (0.39–0.44) | 2,823 | 820,241 | 34.4 | <.0001 |
4th quartile (0.45–0.65) | 2,717 | 558,431 | 48.7 | <.0001 |
Community-onset non-hospital-associated (CO-NHA) CDI per 10,000 admissions | ||||
1st quartile (3–35) | 2,180 | 965,859 | 22.6 | Reference |
2nd quartile (36–56) | 2,700 | 733,345 | 36.8 | <.0001 |
3rd quartile (57–89) | 2,374 | 644,295 | 36.8 | <.0001 |
4th quartile (90–273) | 3,051 | 636,034 | 48.0 | <.0001 |
Average length of stay, days | ||||
1st quartile (2.3–3.4) | 1,433 | 524,973 | 27.3 | Reference |
2nd quartile (3.5–3.9) | 2,213 | 680,684 | 32.5 | <.0001 |
3rd quartile (4.0–4.4) | 2,898 | 814,563 | 35.6 | <.0001 |
4th quartile (4.5–6.0) | 3,761 | 959,313 | 39.2 | <.0001 |
Proton pump inhibitor use, days of therapy per 1,000 days present | ||||
1st quartile (107–265) | 2,224 | 756,480 | 29.4 | Reference |
2nd quartile (266–335) | 2,610 | 857,357 | 30.4 | .2262 |
3rd quartile (336–372) | 2,545 | 641,402 | 39.7 | <.0001 |
4th quartile (372–701) | 2,926 | 724,294 | 40.4 | <.0001 |
Hospital teaching status | ||||
Nonteaching (n=105) | 4,719 | 1,436,414 | 32.9 | Reference |
Teaching (n=66) | 5,586 | 1,543,119 | 36.2 | <.0001 |
Hospital geographic region | ||||
West (n=19) | 915 | 289,972 | 31.6 | Reference |
Northeast (n=26) | 1,791 | 418,282 | 42.8 | <.0001 |
Midwest (n=48) | 2,803 | 808,738 | 34.7 | 0.0135 |
South (n=78) | 4,796 | 1,462,541 | 32.8 | 0.2846 |
Note. CDI, Clostridioides difficile infection.